Cure My Disease

Don't miss your cure!

 Log in / Sign up

Protein and saline mist may cut bleeding risk after tonsil removal

NCT ID NCT07792057

Disease control Sponsor: Hospital Felicio Rocho Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This trial tests whether giving patients extra protein and saline mist after tonsillectomy helps them heal faster and avoid complications. Tonsil removal is common in children and adults, but it often causes pain, trouble swallowing, and a risk of bleeding. The researchers will compare patients who receive the special nutrition and hydration care with those who get standard care, tracking bleeding episodes, pain scores, and healing. The goal is to see if these simple additions can make recovery smoother and safer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Optimized protein nutrition and mucosal humidification via micronebulization with saline
What this could lead to
If it works, this could establish a simple, low-cost care routine that speeds recovery, eases pain, and lowers the risk of serious bleeding after tonsillectomy.
What could go wrong
The trial is still testing the idea, and results may not show a clear benefit. Also, some patients may not tolerate the supplements or nebulization, and bleeding risk varies by individual.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing elective tonsillectomy. * Age ≥ 2 years * Signature of the Informed Consent Form (ICF) by participants aged 18 years or older, or by parents/legal guardians for those under 18, accompanied by the signature of the Informed Assent Form (IAF) by the minor participant, respecting their capacity for understanding. Exclusion Criteria: * Hematologic disorders: Patients with coagulopathies or severe blood abnormalities. * Oral/enteral route: Patients with a contraindication to oral or enteral intake. * Neoplasms: Patients with active neoplasia. * Hypersensitivity: Patients with known allergies to dietary components or nebulization solutions. * Anatomic anomalies: Presence of oropharyngeal abnormalities that could compromise healing regardless of the intervention. * Lack of consent: Formal refusal to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bleeding are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemorrhage hemorrhagic disease nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bleeding Healing Nutrition Tonsillectomy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Felicio Rocho

    Belo Horizonte, Minas Gerais, 30110-934, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.